Skip to main content
TipRanks
Go Ultimate75% OFF

Peter Meldrum Insider Profile

4 Followers

Peter Meldrum, President & C.E.O., Director at Myriad Genetics, holds 2.25K shares in Endocyte (Ticker: ECYT), holds 10.42K shares in Myriad Genetics (Ticker: MYGN).

Peter Meldrum's Trading History

ECYT
Endocyte
May 05, 2017―Uninformative Buy―$53.98K
MYGN
Myriad Genetics
May 08, 2015President & C.E.O., DirectorInformative Buy99.99K$59.10K

You May Also Like

Peter Meldrum insider profile FAQ

What is the percentage of profitable transactions made by Peter Meldrum?
The percentage of profitable transactions made by Peter Meldrum is 67%.
What is the average return per transaction made by Peter Meldrum?
The average return per transaction made by Peter Meldrum is 6.10%.
What stocks does Peter Meldrum hold?
Peter Meldrum holds: MYGN, ECYT stocks.
What was Peter Meldrum's most profitable transaction?
Peter Meldrum’s most profitable transaction was an Informative Buy of MYGN stock on November 6, 2014. The return on the trade was 26.70%.
What is Peter Meldrum's role in Myriad Genetics?
Peter Meldrum's role in Myriad Genetics is President & C.E.O., Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.